![]() |
National Vaccine Information Center Your Health. Your Family. Your Choice. |
MedAlerts Home |
| Table |
![]() | ![]() | |
| Age | Count | Percent |
| < 3 Years | 1 | 0.02% |
| 12-17 Years | 7 | 0.16% |
| 17-44 Years | 505 | 11.78% |
| 44-65 Years | 929 | 21.67% |
| 65-75 Years | 605 | 14.11% |
| 75+ Years | 579 | 13.51% |
| Unknown | 1,661 | 38.75% |
| TOTAL | 4,287 | 100% |
| Case Details |
Administered by: Unknown Purchased by: ?
Life Threatening? No Write-up: had a patient receive COVID vaccine and 3 days later developed bilateral pulmonary embolisms; This is a spontaneous report from a contactable physician. A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration at single dose on an unspecified date for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The physician had a patient receive COVID vaccine and 3 days later developed bilateral pulmonary embolisms on an unspecified date with outcome of unknown. Have there been any similar reports of such events within short time frame of receiving the vaccine? Information about lot/batch number has been requested.; Sender''s Comments: The information provided is limited and doesnot allow a full medically meaningful assessment. This case will be reassessed should additional information, especially patient age, relevant medical history, concomitant drugs and clinical course, become available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate. | |||||||||||||||||||
Administered by: Private Purchased by: ?
Life Threatening? No Write-up: Patient (myself) developed DVT/PE diagnosed on 1/4/2021 | |||||||||||||||||||
Administered by: Other Purchased by: ?
Life Threatening? No Write-up: rib pain/shortness breath/Pulmonary Embolus and viral pneumonia Narrative: Development of symptoms beyond the 48-72 window. Tested at time of ER visit Negative for Covid. Repeated Covid NP swab on 01/05/2021. Was not hospitalized overnight discharge home on oral anticoagulant medications. | |||||||||||||||||||
Administered by: Work Purchased by: ?
Life Threatening? No Write-up: SOB started Saturday 01/02/2021 continued SOB Sunday 01/03/2021 and on Monday 01/04/2021 went to clinic and saw a provider. Resulted in bilateral pulmonary emboli treated with Lovenox and Coumadin. | |||||||||||||||||||
Administered by: Private Purchased by: ?
Life Threatening? No Write-up: Presented to ED 1/3/2021 Tachycardia, fever, headache and myalgia. Complaints of shortness of breath. | |||||||||||||||||||
Administered by: Private Purchased by: ?
Life Threatening? No Write-up: Day 2 (12/29/20): Fever (<100 degrees), Mild muscle aches, Fatigue Day 3 (12/30/20): Fatigue, Muscle aches Day 4 (12/31/20): Alternating chills and profuse sweating starting at 8am, Full body flushing, Grand Mal Seizure at 4:30pm | |||||||||||||||||||
Administered by: Senior Living Purchased by: ?
Life Threatening? No Write-up: On 12/31/2020, at approximately 00:15, pt developed a fever of 102.9 F and tachycardia with rate of 120. He was treated with acetaminophen. Later in the morning, he complained of nausea, generalized muscle aches, intermittent increase in confusion. At approximately 14:00, he had a fall out of bed and at that time noted to be short of breath, tachypneic. He was taken via ambulance to Emergency Department. From there he was transferred to Hospital for admission with acute respiratory distress, suspected sepsis with lactic acid 7.4 and Bilateral Pulmonary Emboli. He was started on heparin and broad spectrum antibiotics and transitioned to ELIQUIS on 1/3/2021. Infectious etiology of sepsis was unclear. He continued broad spectrum antibiotics with clinical improvement. Abdominal CT scan was obtained due to intermittent nausea, vomiting, abdominal pain, loose stools. His heart rhythm flipped to Atrial Fibrillation with RVR on 1/2 and his rate improved with titration of metoprolol. He was also treated with prednisone for suspected underlying undiagnosed COPD. It is noted in his hospital summary that PEs presumed provoked in the setting of his recent COVID 19 infection. He was discharged from the hospital on 1/8/2021 and readmitted to the Veterans Home. He has been stable. | |||||||||||||||||||
Administered by: Private Purchased by: ?
Life Threatening? No Write-up: Back pain, bilateral PE and DVT | |||||||||||||||||||
Administered by: Private Purchased by: ?
Life Threatening? Yes Write-up: I was short of breath and went to emergency room on 1/5/2021. I was diagnosed with bilateral pulmonary embolisms. I was Covid negative and had no other symptoms. | |||||||||||||||||||
Administered by: Other Purchased by: ?
Life Threatening? No Write-up: Developed pulmonary embolism in right lung one week after vaccination. Sharp pain on right side when breathing. Treated with IV Apixaban while inpatient for 2 days, oral Apixaban 5 mg, 2 tabs twice daily 1/5/21-1/11/21, then one 5 mg tab twice a day. Pain has subsided as of 1/14/21. | |||||||||||||||||||
Link To This Search Result:
https://medalerts.org/vaersdb/findfield.php?TABLE=ON&GROUP1=AGE&EVENTS=ON&SYMPTOMS=Pulmonary+embolism+%2810037377%29&VAX=COVID19
Copyright ©
2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166